Specialize with TECH! This Professional Master's Degree in Transfusion Medicine and Patient Blood Management is the program you were looking for to boost your academic career towards excellence"

Allogeneic transfusion remains the most useful and rapid therapeutic tool for the replacement of blood components after acute blood loss. However, we are increasingly aware of its limitations and undesirable effects on polytransfused patients, both in terms of adverse infusion reactions and its influence on their morbidity and mortality during hospitalization. On the other hand, it is necessary to optimize the use of a limited and costly resource coming from blood donors, collaborating to maintain a sustainable health system.

Therefore, in this TECH Professional Master's Degree, students will learn the different strategies and current recommendations for restrictive therapy of hemocomponents in the management of the bleeding patient (Patient Blood Management) and the correct use of other blood derivatives, in a didactic way with examples of common practice and with a main focus on patient safety. 

Therefore, a broad approach to the entire transfusion system is proposed, in its different areas, pre-transfusion - post-transfusion, patients with or without acute bleeding, medical or surgical patients in its three pillars of care (pre-, intra- and post-operative), as well as in the areas of donation and processing of blood components, according to current quality standards, the importance of pre-transfusion tests and the development of a robust hemovigilance system, together with various topics of paramount knowledge and management in transfusion medicine.

It also includes 10 exclusive Masterclasses, designed by a prestigious international expert specialized in Transfusion Medicine. Therefore, it is a 100% online Professional Master's Degree that provides students with the ease of being able to study it comfortably, wherever and whenever they want. All they need is a device with Internet access to take their career one step further. A modality in line with the current times with all the guarantees to position the medical professional in a highly demanded field. 

Bet on TECH! Benefit from the 10 additional Masterclasses included in this program, taught by an internationally renowned expert in Transfusion Medicine" 

This Professional master’s degree in Transfusion Medicine and Patient Blood Management contains the most complete and up-to-date scientific program on the market. The most important features include:

• The development of practical cases presented by experts in transfusion medicine and Patient Blood Management
• The graphic, schematic, and practical contents with which they are created, provide scientific and practical information on the disciplines that are essential for professional practice
• Practical exercises where the self-assessment process can be carried out to improve learning
• With a special emphasis on evidence-based medicine and research methodologies in the field of transfusion medicine
• Theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments
• Content that is accessible from any fixed or portable device with an Internet connection

Learn more about the different methods to reduce intraoperative bleeding and learn the main indications and thresholds for blood transfusion from the best professionals"

The program’s teaching staff includes professionals from the sector who contribute their work experience to this educational program, as well as renowned specialists from leading societies and prestigious universities.

The multimedia content, developed with the latest educational technology, will provide the professional with situated and contextual learning, i.e., a simulated environment that will provide immersive education programmed to learn in real situations.

This program is designed around Problem-Based Learning, whereby the professional must try to solve the different professional practice situations that arise during the course. For this purpose, the professional will be assisted by an innovative interactive video system created by renowned and experienced experts.

Thanks to this Professional master’s degree, you will perfectly understand the process of blood and blood components donation"

You will master the strategies to increase red blood cell mass, especially in patients who will undergo high bleeding risk surgeries, contributing to their well-being and early improvement"

The structure of the contents of this Professional Master's Degree has been designed based on the requirements of Transfusion Medicine, in order for professionals to deepen and update their knowledge in this medical field, with special emphasis on Patient Blood Management. Aware of the relevance of the current relevance of their specialization, the teachers of this program have developed an agenda whose content offers a broad perspective of everything involved in the procedure of blood transfusion, from pre-transfusion tests, through immunohematology to the various strategies for saving blood in the intraoperative setting, among others. Therefore, students will acquire the skills to develop professionally in this area of medicine thanks to a complete program and the best teaching methodology. 

A syllabus developed by experts in Transfusion Medicine totally focused to achieve success in your professional goal, medical excellence" 

Module 1. Blood Donation, Self-Donation and Pre-Transfusion Testing

1.1. Donation of Blood and Blood Components

1.1.1. Technical Requirements and Minimum Conditions for Hemodonation and Transfusion Centers and Transfusion Services
1.1.2. The Principle of Altruism
1.1.3. Data Protection and Confidentiality

1.2. The Whole Blood and Component Donation Process

1.2.1. Donor Selection
1.2.2. Donor Recognition and Donation Verification
1.2.3. Donation of Components by Apheresis 

1.3. Adverse Effects of Donation 

1.3.1. Incidents Related to Whole Blood Donation and Apheresis
1.3.2. Effects Related to the Administration of Citrate

1.4. The Analysis of Blood Donation

1.4.1. Immunohematological and Complementary Analysis 
1.4.2. Microbiological Analysis 

1.5. Prescription and Administration of Blood and Blood Components

1.5.1. Guide to the Transfusion of Blood Components and Plasma Derivatives of the Spanish Society of Blood Transfusion, 5th edition.
1.5.2. Request for Transfusion and Pre-Transfusion Samples 

1.6. Pre-Transfusion Testing

1.6.1. Plate, Tube and Gel Techniques

1.7. Alternatives to Allogeneic Blood Transfusion

1.7.1. Autotransfusion: Autologous Donation and Autotransfusion 
1.7.2. Exclusion Criteria for Autologous Donations
1.7.3. The Utility of Autotransfusion 

1.8. Directed Blood Component Donation

1.8.1. Indications for Directed Donation 

1.9. Encouraging Donation 
1.10. Hemovigilance

1.10.1. Incidents Related to the Donation and Processing of Blood Components
1.10.2. Transfusion-related Incidents
1.10.3. The Look Back

Module 2. Immunohematology

2.1. Red Blood Cell Immunohematology

2.1.1. ABO, Rh and Other Blood Grouping Systems
2.1.2. Classification of Blood Grouping Systems 

2.2. Platelet Immunohematology

2.2.1. Antigens and Platelet Antibodies
2.2.2. Study Techniques and Clinical Significance
2.2.3. Study of Alloimmune Neonatal Thrombopenia 

2.3. Leukocyte Immunohematology 

2.3.1. The HLA System Antigens and Leukocyte Antibodies
2.3.2. Study Techniques and Clinical Significance 

2.4. Autoimmune Hemolytic Anemia 

2.4.1. Immunohematological Tests 

2.5. Hemolytic Disease of the Fetus and Newborn

2.5.1. HDN due to Anti-D and Other Erythrocyte Groups

2.6. Platelet Refractoriness 

2.6.1. Diagnosis and Management 

2.7. Rare Phenotypes

2.7.1. Diagnosis of Rare Phenotypes

2.8. The Panagglutination Problem in Pretransfusion Compatibility Tests

2.8.1. Diagnostic Approach 

2.9. TRALI or Transfusion-Related Acute Lung Injury

2.9.1. Vlaar's Classification of Pulmonary Complications of Transfusion

2.10. The Indication for Transfusion of Phenotype-Matched Blood

Module 3. Allogeneic Transfusion and Patient Blood Management (PBM) Overview

3.1. Patient Blood Management (PBM) 

3.1.1. The Fundamentals of Patient Blood Management 

3.2. Current Legislation 

3.2.1. The World Health Organization
3.2.2. The European Commission 

3.3. Recommendations for Implementing a Patient Blood Management Program 

3.3.1. Organization and Role of Each Member 

3.4. Cost/Benefit Analysis 

3.4.1. Current Situation in Neighboring Countries 

3.5. Restrictive Therapy 
3.6. Red Blood Cell Concentrate Transfusion Thresholds 

3.6.1. Recommendations Not to Do 

3.7. Therapeutic and Prophylactic Use of Platelet Transfusion 

3.7.1. Factors Affecting Platelet Yield 
3.7.2. Contraindications 

3.8. Damage from Storage 
3.9. Other Blood Derivatives and Prohemostats 

3.9.1. Fibrinogen 
3.9.2. Antithrombin 
3.9.3. Tranexamic Acid 
3.9.4. Desmopressin 
3.9.5. Prothrombin Complexes and rFVIIa 

Module 4. Transfusion in Pediatrics

4.1. Transfusion Medicine in Pediatrics 

4.1.1. Optimal Transfusion Volumes 
4.1.2. Indication of Irradiated Components in Pediatrics 

4.2. Transfusion of Intrauterine Hemocomponents 

4.2.1. Current Indications for Intrauterine Transfusion 

4.3. Red Blood Cells Transfusion in Children Younger than 4 Months of Age 

4.3.1. Preterm Anemia 
4.3.2. Red Blood Cell Concentrate Transfusion Thresholds 

4.4. Platelet Transfusion in Children Younger than 4 Months of Age 

4.4.1. Prophylactic Platelet Transfusion 
4.4.2. Alloimmune Neonatal Thrombopenia 

4.5. Plasma Transfusion in Children Younger 4 Months of Age 

4.5.1. Indications for Fresh Frozen Plasma in the Neonatal Period 

4.6. Exchange Transfusion 

4.6.1. Indications 
4.6.2. Complications of Exchange Transfusion 

4.7. Red Blood Cells Transfusion in Children Older than 4 Months of Age 

4.7.1. Anemia in Hemato-Oncology Patients 
4.7.2. Management of Massive Hemorrhage in Pediatrics 

4.8. Platelet Transfusion in Children Older than 4 Months of Age 

4.8.1. Therapeutic Platelet Transfusion Thresholds 

4.9. Plasma Transfusion in Children Older than 4 Months of Age 

4.9.1. Acute Hemorrhage in Hemophiliac Patients 

4.10. Immunoglobulin Administration 

4.10.1. Update on ITP Treatment in Pediatrics 

Module 5. Transfusion and Blood Saving Strategies in Special Situations

5.1. Women of Childbearing Age 

5.1.1. Transfusion Considerations 
5.1.2. Alloantibodies with Gestational Significance 

5.2. Pregnant Woman 

5.2.1. Anemia and Pregnancy 
5.2.2. Use of Erythropoietin in Pregnancy 

5.3. Tolerance of Anemia in Elderly Patients 

5.3.1. Most Frequent Causes 
5.3.2. Factors that Lead to Hemorrhage in Elderly Patients 

5.4. Transfusion in Elderly Patients 

5.4.1. Transfusion Thresholds 
5.4.2. Risk of Water Overload and Acute Pulmonary Edema 

5.5. Anemia in Patients With Ischemic Heart Disease and Heart Failure 

5.5.1. Mechanisms of Anemia in Patients with Cardiomyopathy 
5.5.2. Use of Erythropoietic Agents 
5.5.3. Transfusion Thresholds 

5.6. Anemia in Chronic Kidney Disease Patients 

5.6.1. Mechanisms of Anemia in Chronic Kidney Disease Patients 
5.6.2. Use of Erythropoietic Agents 

5.7. Anemia in the Emergency Department 

5.7.1. Diagnosis of Anemia in the Emergency Department 
5.7.2. Management of Anemia in the Emergency Department 

5.8. Massive and/or Life-Threatening Hemorrhage in the Emergency Department 

5.8.1. Resuscitation and Stabilization 
5.8.2. Hemorrhage Control 

5.9. Immune Thrombocytopenic Purpura in Adults 

5.9.1. Management in the Emergency Department 

5.10. Acute Complications in Sickle Cell Anemia Patients 

5.10.1. Management of Acute Complications 
5.10.2. Recommendations for Blood Transfusion

Module 6. Processing of Blood Components

6.1. Obtaining Blood Components by Whole Blood Fractionation

6.1.1. Fractionation of Whole Blood and Apheresis Procedures 
6.1.2. Anticoagulant and Preservative Solutions
6.1.3. Leukodepletion of Blood Components
6.1.4. Cryoprecipitate

6.2. Apheresis Procedures in Blood Component Donation

6.2.1. Mono and Multicomponent Apheresis 
6.2.2. Apheresis Machines

6.3. Quality Requirements for Blood and Blood Components

6.3.1. The Transfusion Accreditation Committee's Hemotherapy Standards

6.4. Whole Blood and Red Blood Cell Concentrates

6.4.1. Indications for Whole Blood and Red Blood Cell Concentrate
6.4.2. Modifications of Red Blood Cell Components: Washing, Aliquoting, Irradiation and Inactivation of Pathogens

6.5. Therapeutic Platelet Units

6.5.1. Indications for Platelet Transfusion
6.5.2. Modifications of Platelet Components: Washing, Aliquoting, Irradiation and Inactivation of Pathogens, Reconstituted Whole Blood

6.6. Plasma as a Blood Component

6.6.1. Transfusion and Industrial Use
6.6.2. The Production of Plasma Derivatives
6.6.3. The Case of Hyperimmune Plasma and its Use in the SARS-CoV-2 Pandemic

6.7. Cryopreservation of Blood Components

6.7.1. Cryopreservation Techniques Applied to Blood Components
6.7.2. The Use of Cryopreserved Blood Components

6.8. Irradiation of Blood Components

6.8.1. Sources Used for Irradiation
6.8.2. Blood Components that Can Be Irradiated 
6.8.3. Indications for Irradiated Blood Components

6.9. Pathogen Inactivation Techniques in Blood Components

6.9.1. Utility of Blood Components 

Module 7. Therapeutic Apheresis

7.1. Apheresis Techniques 

7.1.1. Techniques and Types of Replacement 
7.1.2. Apheresis in Pediatrics 

7.2. Complications and Adverse Effects 

7.2.1. Complications Related to the Technique 
7.2.2. Adverse Effects Related to the Anticoagulant Used and Venous Accesses
7.2.3. Adverse Effects Related to the Replenishment Volume 

7.3. General Apheresis Procedure 

7.3.1. Types of Venous Access

7.4. Patient Assessment for Apheresis 

7.4.1. Donor/Patient Assessment
7.4.2. Informed Consent 

7.5. Therapeutic Apheresis in Hematology: Progenitor Transplantation 

7.5.1. Apheresis for Hematopoietic Progenitor Donation, for Autologous and Allogeneic Transplantation
7.5.2. Donor Lymphocyte Apheresis

7.6. Therapeutic Apheresis in Hematology: Plasma Exchange 

7.6.1. Thrombotic Thrombocytopenic Purpura 

7.7. Therapeutic Apheresis in Hematology: Other Situations

7.7.1. Erythroapheresis 
7.7.2. Leukoapheresis 
7.7.3. Platelet Apheresis

7.8. Therapeutic Apheresis in Solid Organ Rejection

7.8.1. Indications for Solid Organ Transplants 

7.9. Therapeutic Apheresis in Neurological Pathology: 

7.9.1. Indications in Neurological Pathology 

7.10. Therapeutic Apheresis in Renal Pathology

7.10.1. Indications in Neurological Pathology 

Module 8. Strategies for Blood Saving in the Preoperative Setting

8.1. Preoperative Anemia 

8.1.1. Diagnostic Algorithm 

8.2. Iron Deficiency Anemia 

8.2.1. Use of Intravenous Iron 

8.3. Anemia in Oncology Patients 

8.3.1. Anemia Mechanisms 

8.4. Erythropoietin 

8.4.1. Erythropoietin Indications 

8.5. Hemorrhagic Risk Assessment 

8.5.1. Patient Factors 
8.5.2. Procedural Factors 

8.6. Thrombotic Risk Assessment 

8.6.1. Patient Factors 
8.6.2. Procedural Factors 

8.7. Bridge Therapy and Preoperative Recommendations 

8.7.1. Dicoumarinics 
8.7.2. Direct Acting Anticoagulants 

8.8. Preoperative Recommendations for Antiplatelet Therapy 

8.8.1. Low Hemorrhagic Risk Surgery 
8.8.2. High Hemorrhagic Risk Surgery 

8.9. Preoperative Recommendations in Patients with Congenital Coagulopathies

8.9.1. Low Hemorrhagic Risk Surgeries 
8.9.2. High Hemorrhagic Risk Surgeries 

8.10. The Jehovah's Witness Patient 

8.10.1. Basics of Transfusion Rejection 
8.10.2. Conclusions 

Module 9. Strategies for Blood Saving in the Intraoperative Setting

9.1. Identification and Monitoring of Intraoperative Hemostasis Disorders 
9.2. Anesthetic and Surgical Techniques to Reduce Intraoperative Bleeding 

9.2.1. Intraoperative Fluid Therapy 

9.3. Administration of Prohemostats 

9.3.1. Plasma and Platelet Administration 
9.3.2. Administration of Antifibrinolytics 
9.3.3. Fibrinogen and Cryoprecipitates 
9.3.4. Prothrombin Complex Concentrate 

9.4. Autologous Transfusion Methods

9.4.1. Acute Normovolemic Hemodilution 
9.4.2. Autologous Blood Transfusion 

9.5. Intraoperative Blood Component Transfusion 

9.5.1. Transfusion Thresholds 

9.6. Cardiac Surgery 

9.6.1. Fluid Therapy in Cardiac Surgery
9.6.2. Transfusion Algorithms and Transfusion Thresholds 

9.7. Pediatric and Obstetric Surgery 

9.7.1. Obstetric Hemorrhage 
9.7.2. Transfusion Recommendations for Neonates in the Intraoperative Setting 

9.8. Orthopedic Surgery and Traumatology 

9.8.1. Risks for Transfusion in Orthopedic Surgery Patient

9.9. Refusal of Allogeneic Blood Transfusion 

9.9.1. Alternatives to Allogeneic Blood Transfusion in Patients Refusing Transfusion

9.10. Acute Hemorrhage and Massive Transfusion 

9.10.1. Main Intraoperative Causes
9.10.2. Strategies in Antiplatelet/Anticoagulated Patients and Emergency Surgery 

Module 10. Blood Saving Strategies in the Postoperative and Critically Ill Patient Setting.

10.1. Mechanisms of Anemia in Critical Patients 

10.1.1. Etiopathogenesis 

10.2. Mechanisms of Coagulopathy in Critical Patients 

10.2.1. Disseminated Intravascular Coagulation 

10.3. Management of Anticoagulation and Antithrombotic Prophylaxis 

10.3.1. Thromboprophylaxis 
10.3.2. Anticoagulation 

10.4. Early Diagnosis and Treatment of Infections 

10.4.1. Strategies for Early Diagnosis of Infections and Prevention of Sepsis 

10.5. Optimization of Anemia Tolerance 

10.5.1. Use of Erythropoietic Agents in Critically Ill Patients 

10.6. Transfusion Thresholds in Critically Ill Patients 

10.6.1. "Do“Not-Do" Practices in the Use of Blood Components 

10.7. Controlled Hypotension 

10.7.1. Indications 
10.7.2. Physiological Response of the Organism 

10.8. Gastrointestinal Bleeding 

10.8.1. Managing Hepatopathic Patients 
10.8.2. Gastrointestinal Bleeding Prophylaxis 

10.9. Intracranial Hemorrhage Management 

10.9.1. Use of Prohemostatic Agents 

10.10. Management and Indications of the Extracorporeal Membrane Oxygenation System (ECMO) 

10.10.1. Venoarterial ECMO 
10.10.2. Venovenous ECMO 
10.10.3. Transfusion Thresholds 

A unique, key and decisive training experience to boost your professional development"